CA2162497A1
(en)
|
1993-06-10 |
1994-12-22 |
Sheila Connelly |
Adenoviral vectors for treatment of hemophilia
|
EP1548118A2
(en)
*
|
1994-06-10 |
2005-06-29 |
Genvec, Inc. |
Complementary adenoviral vector systems and cell lines
|
US6281010B1
(en)
*
|
1995-06-05 |
2001-08-28 |
The Trustees Of The University Of Pennsylvania |
Adenovirus gene therapy vehicle and cell line
|
US5756283A
(en)
*
|
1995-06-05 |
1998-05-26 |
The Trustees Of The University Of Pennsylvania |
Method for improved production of recombinant adeno-associated viruses for gene therapy
|
US6004797A
(en)
*
|
1995-11-09 |
1999-12-21 |
Avigen, Inc. |
Adenovirus helper-free recombinant AAV Virion production
|
ES2208942T3
(es)
*
|
1996-07-05 |
2004-06-16 |
Philip E. Branton |
Proteinas e4 de adenovirus para inducir la muerte celular.
|
US6730662B1
(en)
|
1996-07-05 |
2004-05-04 |
Mcgill University |
Adenovirus E4 proteins for inducing cell death
|
NZ508399A
(en)
*
|
1996-09-25 |
2003-06-30 |
Novartis Ag |
Packaging cell lines for use in facilitating the development of high capacity adenoviral vectors
|
US7232899B2
(en)
|
1996-09-25 |
2007-06-19 |
The Scripps Research Institute |
Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
|
US6261823B1
(en)
|
1996-12-13 |
2001-07-17 |
Schering Corporation |
Methods for purifying viruses
|
US6544769B1
(en)
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
US6146891A
(en)
|
1997-01-31 |
2000-11-14 |
Schering Corporation |
Methods for cultivating cells and propagating viruses
|
US6168944B1
(en)
|
1997-01-31 |
2001-01-02 |
Schering Corporation |
Methods for cultivating cells and propagating viruses
|
WO1998039411A1
(en)
*
|
1997-03-04 |
1998-09-11 |
Baxter International Inc. |
Adenovirus e1-complementing cell lines
|
CA2288306A1
(en)
|
1997-04-28 |
1998-11-05 |
Rhone-Poulenc Rorer S.A. |
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
|
CA2294649C
(en)
|
1997-06-23 |
2007-09-25 |
University Of Saskatchewan |
Bovine adenovirus type 3 genome
|
US6512161B1
(en)
|
1998-01-08 |
2003-01-28 |
Aventis Pharmaceuticals, Inc. |
Transgenic rabbit that expresses a functional human lipoprotein (a)
|
AU750972B2
(en)
*
|
1998-02-17 |
2002-08-01 |
Genzyme Corporation |
Methods for purified AAV vector production
|
FR2777570A1
(fr)
*
|
1998-04-17 |
1999-10-22 |
Transgene Sa |
Mutant ayant une activite phosphoribosyl transferase
|
US6225456B1
(en)
|
1998-05-07 |
2001-05-01 |
University Technololy Corporation |
Ras suppressor SUR-5
|
US6506889B1
(en)
|
1998-05-19 |
2003-01-14 |
University Technology Corporation |
Ras suppressor SUR-8 and related compositions and methods
|
GB9811171D0
(en)
*
|
1998-05-22 |
1998-07-22 |
Royal Free Hosp School Med |
Viral vector
|
GB9811172D0
(en)
*
|
1998-05-22 |
1998-07-22 |
Royal Free Hosp School Med |
Virus production
|
AU780822B2
(en)
*
|
1998-11-02 |
2005-04-21 |
University Of Saskatchewan |
Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
|
US6441156B1
(en)
|
1998-12-30 |
2002-08-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Calcium channel compositions and methods of use thereof
|
US7960540B2
(en)
|
1999-04-08 |
2011-06-14 |
Advanced Cancer Therapeutics, Llc |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
|
US8114850B2
(en)
|
1999-04-08 |
2012-02-14 |
Advanced Cancer Therapeutics, Llc |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
|
AU775412B2
(en)
|
1999-04-08 |
2004-07-29 |
Advanced Cancer Therapeutics, Inc. |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
|
FR2794771B1
(fr)
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
MXPA02009481A
(es)
|
2000-03-31 |
2004-05-14 |
Aventis Pharma Inc |
Factor inductor del factor nuclear kb.
|
GB0018307D0
(en)
|
2000-07-26 |
2000-09-13 |
Aventis Pharm Prod Inc |
Polypeptides
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
DE10066104A1
(de)
*
|
2000-09-08 |
2003-01-09 |
Medigene Ag |
Wirtszellen zur Verpackung von rekombinantem Adeno-assoziiertem Virus (rAAV), Verfahren zu ihrer Herstellung und deren Verwendung
|
MXPA03005386A
(es)
|
2000-12-28 |
2004-04-20 |
Wyeth Corp |
Proteina protectora recombinante de streptococcus pneumoniae.
|
AUPR518501A0
(en)
|
2001-05-22 |
2001-06-14 |
Unisearch Limited |
Yin yang-1
|
US6677156B2
(en)
*
|
2001-07-23 |
2004-01-13 |
Genvec, Inc. |
Non-adenoviral gene product-based complementing cells for adenoviral vectors
|
US6682929B2
(en)
|
2001-07-23 |
2004-01-27 |
Genvec, Inc. |
Adenovector complementing cells
|
US20030129203A1
(en)
*
|
2001-08-27 |
2003-07-10 |
Nautilus Biotech S.A. |
Mutant recombinant adeno-associated viruses
|
US7647184B2
(en)
*
|
2001-08-27 |
2010-01-12 |
Hanall Pharmaceuticals, Co. Ltd |
High throughput directed evolution by rational mutagenesis
|
AU2002332736A1
(en)
*
|
2001-08-30 |
2003-03-18 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of |
New adenovirus type 7 vectors
|
US20040023910A1
(en)
*
|
2001-09-28 |
2004-02-05 |
Zhiming Zhang |
Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
US20030224404A1
(en)
*
|
2002-02-25 |
2003-12-04 |
Manuel Vega |
High throughput directed evolution of nucleic acids by rational mutagenesis
|
KR101006594B1
(ko)
*
|
2002-04-25 |
2011-01-07 |
크루셀 홀란드 비.브이. |
안정한 아데노바이러스 벡터 및 그 증식 방법
|
EP1504125B1
(en)
|
2002-05-15 |
2008-10-29 |
Integragen |
Human obesity susceptibility gene and uses thereof
|
US7217796B2
(en)
|
2002-05-24 |
2007-05-15 |
Schering Corporation |
Neutralizing human anti-IGFR antibody
|
CA2495546A1
(en)
*
|
2002-08-22 |
2004-03-04 |
Merck & Co., Inc. |
Methods for propagating adenovirus and virus produced thereby
|
US20050202438A1
(en)
*
|
2002-09-09 |
2005-09-15 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
US20060020396A1
(en)
*
|
2002-09-09 |
2006-01-26 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
CA2498319A1
(en)
*
|
2002-09-09 |
2004-03-18 |
Nautilus Biotech |
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
|
CA2519680A1
(en)
|
2003-03-28 |
2004-11-18 |
The Scripps Research Institute |
Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
|
US7186699B2
(en)
*
|
2003-06-03 |
2007-03-06 |
Cell Genesys, Inc. |
Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
|
CA2526120A1
(en)
*
|
2003-06-03 |
2005-02-24 |
Cell Genesys, Inc. |
Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
|
US7485291B2
(en)
*
|
2003-06-03 |
2009-02-03 |
Cell Genesys, Inc. |
Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
|
EP1649028B1
(en)
*
|
2003-07-25 |
2012-08-22 |
Genvec, Inc. |
Adenoviral vector-based vaccines
|
DE602004021186D1
(de)
|
2003-08-22 |
2009-07-02 |
Integragen Sa |
Menschliches autismus-suszeptibilitätsgen und verwendungen davon
|
EP1687032B1
(en)
|
2003-11-14 |
2010-02-24 |
Genvec, Inc. |
Pharmaceutical composition for treating unresectable, locally advanced pancreatic cancer (lapc).
|
WO2005054438A2
(en)
|
2003-12-01 |
2005-06-16 |
Invitrogen Corporation |
Nucleic acid molecules containing recombination sites and methods of using the same
|
PL1711518T3
(pl)
*
|
2004-01-23 |
2010-06-30 |
St Di Richerche Di Biologia Molecolare P Angeletti S P A |
Nośniki szczepionek pochodzące od szympansich adenowirusów
|
US7432057B2
(en)
|
2004-01-30 |
2008-10-07 |
Michigan State University |
Genetic test for PSE-susceptible turkeys
|
CA2563396A1
(en)
|
2004-04-12 |
2005-11-24 |
The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services |
Method of using adenoviral vectors to induce an immune response
|
US20080193464A1
(en)
|
2004-07-01 |
2008-08-14 |
Anne Philippi |
Human Autism Susceptibility Gene Encoding Prkcb1 and Uses Thereof
|
US7604798B2
(en)
|
2004-07-15 |
2009-10-20 |
Northwestern University |
Methods and compositions for importing nucleic acids into cell nuclei
|
AU2005274948B2
(en)
|
2004-07-16 |
2011-09-22 |
Genvec, Inc. |
Vaccines against aids comprising CMV/R-nucleic acid constructs
|
EP1784493A2
(en)
*
|
2004-09-01 |
2007-05-16 |
The Government of the United States of America as Represented by The Department of Health and Human Services |
Adenoviral vectors able to transduce apcs, potential use in immune response generation
|
US20060057127A1
(en)
*
|
2004-09-10 |
2006-03-16 |
Pocheng Liu |
Cytokine-expressing cellular vaccines for treatment of prostate cancer
|
ATE482290T1
(de)
|
2005-03-24 |
2010-10-15 |
Integragen Sa |
Ein transmembranprotein kodierendes humanes autismus-suszeptibilitätsgen und dessen verwendung
|
US20060234347A1
(en)
*
|
2005-04-13 |
2006-10-19 |
Harding Thomas C |
Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
|
DK2002003T3
(en)
|
2005-05-27 |
2016-03-21 |
Ospedale San Raffaele Srl |
Gene vector comprising miRNA
|
MX2008000985A
(es)
|
2005-07-21 |
2008-04-07 |
Abbott Lab |
Expresion de gen multiple que incluye construcciones y metodos sorf (cuadro de lectura abierta simple) con poliproteinas, pro-proteinas y proteolisis.
|
US8765146B2
(en)
|
2005-08-31 |
2014-07-01 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
US8450055B2
(en)
*
|
2005-08-31 |
2013-05-28 |
The United States Of America As Represented By The Secretary Of The Navy |
Malaria antigen screening method
|
US9651543B2
(en)
|
2005-08-31 |
2017-05-16 |
The United States Of America As Represented By The Secretary Of The Navy |
Malaria antigen screening method
|
BRPI0618441B8
(pt)
|
2005-11-10 |
2021-07-27 |
Genvec Inc |
vetor adenoviral
|
EP1835036A1
(en)
|
2006-03-16 |
2007-09-19 |
Exonhit Therapeutics SA |
Methods and compositions for the detection and treatment of cancers
|
WO2007104792A2
(en)
*
|
2006-03-16 |
2007-09-20 |
Crucell Holland B.V. |
Recombinant adenoviruses based on serotype 26 and 48, and use thereof
|
ES2388567T3
(es)
|
2006-10-19 |
2012-10-16 |
Csl Limited |
Anticuerpos anti-il-13r alfa 1 y usos de los mismos
|
ES2501947T3
(es)
|
2006-10-19 |
2014-10-02 |
Csl Limited |
Antagonistas de anticuerpos de alta afinidad del receptor alfa 1 de interleucina
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
US20080248060A1
(en)
*
|
2007-01-09 |
2008-10-09 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
EP2027868A1
(en)
|
2007-08-24 |
2009-02-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Use of SCO-Spondin peptides for inhibiting or preventing neuronal apoptosis mediated by cell death receptor ligands
|
US20100303828A1
(en)
|
2008-01-31 |
2010-12-02 |
INSERM Institut National de la Sante et de la Recherche Medicale) |
Antibodies Against Human CD39 and Use Thereof for Inhibiting T Regulatory Cells Activity
|
JP2012504946A
(ja)
|
2008-10-07 |
2012-03-01 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
血小板第4因子変異体1(pf4v1)に対する中和抗体およびそのフラグメント
|
KR20110081282A
(ko)
|
2008-11-05 |
2011-07-13 |
와이어쓰 엘엘씨 |
베타―용혈성 연쇄구균 (bhs) 질환의 예방을 위한 다성분 면역원성 조성물
|
EP2199387A1
(en)
|
2008-12-19 |
2010-06-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Serine protease derivatives and uses for the prevention and/or the treatment of blood coagulation disorders
|
CN104262479A
(zh)
|
2008-12-19 |
2015-01-07 |
国家健康与医学研究院 |
丝氨酸蛋白酶衍生物及其在凝血功能障碍的预防或治疗中的用途
|
CA2749192A1
(en)
|
2009-01-20 |
2010-07-29 |
Transgene Sa |
Soluble icam-1 as biomarker for prediction of therapeutic response
|
WO2010096561A1
(en)
|
2009-02-18 |
2010-08-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic hiv/siv gag proteins and uses thereof
|
EP2408818A1
(en)
|
2009-03-17 |
2012-01-25 |
Université de la Méditerranée |
Btla antibodies and uses thereof
|
HUE026194T2
(en)
|
2009-03-24 |
2016-05-30 |
Transgene Sa |
Biomarker for checking patients
|
CN102395883B
(zh)
|
2009-04-17 |
2015-12-02 |
特朗斯吉有限公司 |
用于监控患者的生物标志物
|
EP2427205A2
(en)
|
2009-05-04 |
2012-03-14 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Par2 agonists for use in the treatment or prevention of influenza virus type a infections
|
EP2427497B1
(fr)
|
2009-05-07 |
2016-12-07 |
Stallergenes |
Utilisation d'immunoglobulines igg1 et/ou de ligands du récepteur cd32 pour le traitement de maladies et manifestations inflammatoires par voie mucosale
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
SG176619A1
(en)
|
2009-07-10 |
2012-01-30 |
Transgene Sa |
Biomarker for selecting patients and related methods
|
WO2011047316A1
(en)
|
2009-10-16 |
2011-04-21 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Nucleic acid sequences encoding expandable hiv mosaic proteins
|
WO2011048443A1
(en)
|
2009-10-20 |
2011-04-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neuronal exocytosis inhibiting peptides derived from c subunit of v-atpase and cosmetic and pharmaceutical compositions containing said peptides
|
AU2010313395A1
(en)
|
2009-10-30 |
2012-05-10 |
Abbvie Inc. |
sORF constructs and multiple gene expression
|
WO2011057254A2
(en)
|
2009-11-09 |
2011-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Simian adenoviral vector-based vaccines
|
MX2012005181A
(es)
|
2009-11-09 |
2012-08-01 |
Genvec Inc |
Metodos para la propagacion de vectores adenovirales de monos.
|
WO2011080322A1
(en)
|
2009-12-30 |
2011-07-07 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Method of prognosing the outcome of acquired hemophilia and of treatment of hemophilia
|
US8735171B2
(en)
|
2010-01-13 |
2014-05-27 |
Institut National De La Santé Et De La Recherche Médicale (Inserm) |
Promyelocytic leukemia protein as a redox sensor
|
KR20110103119A
(ko)
*
|
2010-03-12 |
2011-09-20 |
국립암센터 |
신규한 조건부-복제 가능 아데노바이러스 및 그의 제조 방법
|
CN102892429B
(zh)
|
2010-03-17 |
2016-08-31 |
康奈尔大学 |
基于被破坏的腺病毒的抗滥用药物疫苗
|
CA2795390C
(en)
|
2010-04-08 |
2020-11-03 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
|
EP2575853B1
(en)
|
2010-05-25 |
2016-08-24 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient
|
US20130150304A1
(en)
|
2010-07-09 |
2013-06-13 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Treatment of a disease associated with retinal degenerative disorder
|
WO2012010696A1
(en)
|
2010-07-23 |
2012-01-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for cancer management targeting co-029
|
WO2012021730A2
(en)
|
2010-08-11 |
2012-02-16 |
Genvec, Inc. |
Respiratory syncytial virus (rsv) vaccine
|
PT3246044T
(pt)
|
2010-08-23 |
2021-02-15 |
Wyeth Llc |
Formulações estáveis de antigénios de rlp2086 de neisseria meningitidis
|
NZ607224A
(en)
|
2010-09-10 |
2014-11-28 |
Wyeth Llc |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
JP5937088B2
(ja)
|
2010-10-15 |
2016-06-22 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
ハンチントン病の治療法におけるコレステロール−24−ヒドロラーゼのための発現ベクター
|
WO2012080769A1
(en)
|
2010-12-15 |
2012-06-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-cd277 antibodies and uses thereof
|
WO2012083297A2
(en)
|
2010-12-17 |
2012-06-21 |
Genvec, Inc. |
Adenoviral vectors with modified hexon regions
|
US8920813B2
(en)
|
2010-12-20 |
2014-12-30 |
Genvec, Inc. |
Adenoviral vector-based dengue fever vaccine
|
ES2684602T3
(es)
|
2010-12-22 |
2018-10-03 |
Orega Biotech |
Anticuerpos contra CD39 humano y uso de los mismos
|
EP2658869B1
(en)
|
2010-12-30 |
2019-06-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antigen binding formats for use in therapeutic treatments or diagnostic assays
|
WO2012101125A1
(en)
|
2011-01-24 |
2012-08-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Specific antibodies against human cxcl4 and uses thereof
|
WO2012120131A1
(en)
|
2011-03-09 |
2012-09-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for generating cell microparticles
|
WO2012120129A1
(en)
|
2011-03-10 |
2012-09-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment of infectious diseases
|
EP2691419B1
(en)
|
2011-03-31 |
2016-11-09 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Antibodies directed against icos and uses thereof
|
ES2657862T3
(es)
|
2011-05-13 |
2018-03-07 |
Gamamabs Pharma |
Anticuerpos contra HER3
|
US9127065B2
(en)
|
2011-05-19 |
2015-09-08 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Anti-human HER3 antibodies and uses thereof
|
WO2012162428A1
(en)
|
2011-05-23 |
2012-11-29 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Prime-boost vaccination for viral infection
|
EP2721057B1
(en)
|
2011-06-15 |
2019-07-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Polypeptides isolated from brevibacterium aurantiacum and their use for the treatment of cancer
|
US9249228B2
(en)
|
2011-06-22 |
2016-02-02 |
Oribase Pharma |
Anti-Axl antibodies and uses thereof
|
EP2723377B1
(en)
|
2011-06-22 |
2018-06-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-axl antibodies and uses thereof
|
EP2543678A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
EP2543679A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
EP2543677A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
FR2979346B1
(fr)
|
2011-08-23 |
2013-09-27 |
Univ Joseph Fourier |
Nanocorps anti-vcam-1
|
WO2013041901A1
(en)
|
2011-09-20 |
2013-03-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for preparing single domain antibody microarrays
|
IN2014DN03005A
(xx)
|
2011-10-05 |
2015-05-08 |
Genvec Inc |
|
CA2850627C
(en)
|
2011-10-05 |
2024-05-21 |
Genvec, Inc. |
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
|
CN107574154A
(zh)
|
2011-10-05 |
2018-01-12 |
金维克有限公司 |
猴(大猩猩)腺病毒或腺病毒载体及其使用方法
|
WO2013052859A2
(en)
|
2011-10-05 |
2013-04-11 |
Genvec, Inc. |
Adenoviral vector-based respiratory syncytial virus (rsv) vaccine
|
EP2809346A1
(en)
|
2012-02-02 |
2014-12-10 |
GenVec, Inc. |
Adenoviral vector-based malaria vaccine
|
CN110917362A
(zh)
|
2012-02-07 |
2020-03-27 |
全球生物疗法有限公司 |
核酸输送的区室化方法及其组合物和应用
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
NZ628449A
(en)
|
2012-03-09 |
2016-04-29 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
US10039777B2
(en)
|
2012-03-20 |
2018-08-07 |
Neuro-Lm Sas |
Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
|
WO2013174835A1
(en)
|
2012-05-22 |
2013-11-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for screening a candidate compound for its pharmacology on a nuclear receptor
|
EP2855678B1
(en)
|
2012-05-25 |
2017-08-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for selecting binders by phage display and masked selection
|
WO2013180967A1
(en)
|
2012-05-29 |
2013-12-05 |
Genvec, Inc. |
Herpes simplex virus vaccine
|
WO2013181128A1
(en)
|
2012-05-29 |
2013-12-05 |
Genvec, Inc. |
Modified serotype 28 adenoviral vectors
|
WO2014001368A1
(en)
|
2012-06-25 |
2014-01-03 |
Orega Biotech |
Il-17 antagonist antibodies
|
EP2692732A1
(en)
|
2012-08-03 |
2014-02-05 |
Stallergenes S.A. |
Novel allergen from ragweed pollen and uses thereof
|
WO2014033327A1
(en)
|
2012-09-03 |
2014-03-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies directed against icos for treating graft-versus-host disease
|
US9657081B2
(en)
|
2012-09-07 |
2017-05-23 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) TREM-like transcript 1 (TLT-1) for treatment of cardiovascular diseases
|
EP2895191B1
(en)
|
2012-09-14 |
2019-06-05 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Brachyury protein, adenoviral vectors encoding brachyury protein, and their use
|
KR101522341B1
(ko)
*
|
2012-10-02 |
2015-05-21 |
국립암센터 |
신규한 조건부-복제 가능 아데노바이러스 및 그의 제조 방법
|
US20160083712A1
(en)
|
2012-10-12 |
2016-03-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Csn5 polypeptides and uses thereof for screening therapeutic agents
|
EP2733153A1
(en)
|
2012-11-15 |
2014-05-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the preparation of immunoconjugates and uses thereof
|
ES2625742T3
(es)
|
2012-11-20 |
2017-07-20 |
Sanofi |
Anticuerpos anti-CEACAM5 y usos de los mismos
|
EP2749289A1
(en)
|
2012-12-26 |
2014-07-02 |
Institut National De La Recherche Agronomique (INRA) |
Anti-inflammatory peptides
|
US11013783B2
(en)
|
2012-12-26 |
2021-05-25 |
Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement |
Anti-inflammatory peptides and methods for treating inflammatory diseases
|
MX2015008448A
(es)
|
2012-12-27 |
2016-04-07 |
Sanofi Sa |
Anticuerpos anti-lamp1 y conjugados anticuerpo farmaco, y usos de estos.
|
WO2014107739A1
(en)
|
2013-01-07 |
2014-07-10 |
Eleven Biotherapeutics, Inc. |
Antibodies against pcsk9
|
US9066966B2
(en)
|
2013-02-01 |
2015-06-30 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia
|
US9802987B2
(en)
|
2013-03-08 |
2017-10-31 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
EP2968613B1
(en)
|
2013-03-11 |
2019-09-11 |
University of Florida Research Foundation, Inc. |
Delivery of card protein as therapy for occular inflammation
|
DE102013004595A1
(de)
|
2013-03-15 |
2014-09-18 |
Emergent Product Development Germany Gmbh |
RSV-Impfstoffe
|
KR101606910B1
(ko)
|
2013-03-29 |
2016-04-04 |
충북보건과학대학교 산학협력단 |
아데노바이러스 벡터 생산용 a549 기반 세포주
|
ES2698375T3
(es)
|
2013-06-27 |
2019-02-04 |
Inst Nat Sante Rech Med |
Antagonistas de interleucina 15 (IL-15) y usos de los mismos para el tratamiento de enfermedades autoinmunes y enfermedades inflamatorias
|
EP2824176A1
(en)
|
2013-07-11 |
2015-01-14 |
Siamed'xpress |
Methods for producing sialylated therapeutic proteins
|
CA2920261C
(en)
|
2013-08-08 |
2018-04-03 |
Global Bio Therapeutics, Inc. |
Clamp device for minimally invasive procedures and uses thereof
|
EP4098276A1
(en)
|
2013-09-08 |
2022-12-07 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
EP3066203B2
(en)
|
2013-11-05 |
2023-11-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New alzheimer's disease animal model
|
CN105849125B
(zh)
|
2013-11-07 |
2020-05-15 |
国家医疗保健研究所 |
神经调节蛋白变构抗her3抗体
|
MX2016009466A
(es)
|
2014-01-20 |
2017-04-25 |
Sanofi Sa |
Polipeptido de citocromo p450 novedoso con mayor actividad enzimatica.
|
WO2015127094A1
(en)
|
2014-02-19 |
2015-08-27 |
University Of Florida Research Foundation, Inc. |
Delivery of nrf2 as therapy for protection against reactive oxygen species
|
EP3131929B1
(en)
|
2014-04-16 |
2022-06-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the prevention or the treatment of bleeding episodes
|
FR3020063A1
(fr)
|
2014-04-16 |
2015-10-23 |
Gamamabs Pharma |
Anticorps humain anti-her4
|
ES2796857T3
(es)
|
2014-04-17 |
2020-11-30 |
Inst Nat Sante Rech Med |
Polipéptidos y usos de los mismos para reducir la motilidad celular mediada por CD95
|
FR3021970B1
(fr)
|
2014-06-06 |
2018-01-26 |
Universite Sciences Technologies Lille |
Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
|
EP2974735A1
(en)
|
2014-07-15 |
2016-01-20 |
Institut National De La Recherche Agronomique (INRA) |
Anti-inflammatory properties of a surface protein of propionibacterium freudenreichii
|
EP3189067B1
(en)
|
2014-09-04 |
2021-05-19 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Recombinant hiv-1 envelope proteins and their use
|
US10398774B2
(en)
|
2014-12-09 |
2019-09-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Human monoclonal antibodies against AXL
|
US10420834B2
(en)
|
2014-12-24 |
2019-09-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant metapneumovirus F proteins and their use
|
WO2016118642A1
(en)
|
2015-01-20 |
2016-07-28 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Recombinant human/bovine parainfluenza virus 3 (b/hpiv3) expressing a chimeric rsv/bpiv3 f protein and uses thereof
|
PE20171764A1
(es)
|
2015-01-23 |
2017-12-21 |
Sanofi Sa |
Anticuerpos anti-cd3, anticuerpos anti-cd123 y anticuerpos biespecificos que se unen especificamente a cd3 y/o cd123
|
KR20170103009A
(ko)
|
2015-02-19 |
2017-09-12 |
화이자 인코포레이티드 |
나이세리아 메닌지티디스 조성물 및 그의 방법
|
EP3261665A1
(en)
|
2015-02-24 |
2018-01-03 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
|
WO2016135041A1
(en)
|
2015-02-26 |
2016-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fusion proteins and antibodies comprising thereof for promoting apoptosis
|
WO2016150964A1
(en)
|
2015-03-23 |
2016-09-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment and the prevention of neurological phenotype associated with friedreich ataxia
|
EP3091033A1
(en)
|
2015-05-06 |
2016-11-09 |
Gamamabs Pharma |
Anti-human-her3 antibodies and uses thereof
|
US20180125947A1
(en)
|
2015-05-20 |
2018-05-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of retinal detachment
|
US10526415B2
(en)
|
2015-05-22 |
2020-01-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Human monoclonal antibodies fragments inhibiting both the Cath-D catalytic activity and its binding to the LRP1 receptor
|
US20180201687A1
(en)
|
2015-07-07 |
2018-07-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to myosin 18a and uses thereof
|
EP3331554B1
(en)
|
2015-08-03 |
2022-05-11 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use
|
WO2017029391A1
(en)
|
2015-08-20 |
2017-02-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method for treating cancer
|
WO2017046200A1
(en)
|
2015-09-16 |
2017-03-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Specific interleukin-15 (il-15) antagonist polypeptide and uses thereof for the treatment of inflammatory and auto-immune diseases
|
DK3353196T3
(da)
|
2015-09-22 |
2023-02-20 |
Inst Nat Sante Rech Med |
Polypeptider, der er i stand til at inhibere bindingen mellem leptin og neuropilin-1
|
WO2017050955A1
(en)
|
2015-09-24 |
2017-03-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Agents capable of inhibiting the binding between leptin and vegf165
|
KR20180063885A
(ko)
|
2015-09-24 |
2018-06-12 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
전이 감소를 위한 방법 및 조성물
|
EP4119168A1
(en)
|
2016-01-19 |
2023-01-18 |
The Regents of the University of California |
Methods for the treatment of danon disease and other disorders of autophagy
|
WO2017139392A1
(en)
|
2016-02-08 |
2017-08-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant hiv-1 envelope proteins and their use
|
CA3013333A1
(en)
|
2016-02-26 |
2017-08-31 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Antibodies having specificity for btla and uses thereof
|
EP3426291A1
(en)
|
2016-03-09 |
2019-01-16 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Recombinant hiv-1 envelope proteins and their use
|
KR102640157B1
(ko)
|
2016-03-22 |
2024-02-27 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
인간화 항-클라우딘-1 항체 및 이의 용도
|
JP7356224B2
(ja)
|
2016-03-28 |
2023-10-04 |
ウルトラジェニックス ファーマシューティカル インコーポレイテッド |
アデノウイルスの熱不活性化の方法
|
EP3484493A4
(en)
*
|
2016-07-12 |
2019-12-25 |
Ultragenyx Pharmaceutical Inc. |
USE OF GLUCOCORTICOID ANALOGS TO INCREASE THE PERFORMANCE OF RECOMBINANT ADENO-ASSOCIATED VIRUSES
|
TWI790206B
(zh)
|
2016-07-18 |
2023-01-21 |
法商賽諾菲公司 |
特異性結合至cd3和cd123的雙特異性抗體樣結合蛋白
|
US11186634B2
(en)
|
2016-07-29 |
2021-11-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies targeting tumor associated macrophages and uses thereof
|
US20200165302A1
(en)
|
2016-09-14 |
2020-05-28 |
Université Catholique de Louvain |
Modified vsv-g and vaccines thereof
|
CN109715204B
(zh)
|
2016-09-20 |
2023-08-22 |
勃林格殷格翰动物保健有限公司 |
新的ehv插入位点orf70
|
CA3036386A1
(en)
|
2016-09-20 |
2018-03-29 |
Boehringer Ingelheim Vetmedica Gmbh |
Canine adenovirus vectors
|
JP6951429B2
(ja)
|
2016-09-20 |
2021-10-20 |
ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハーBoehringer Ingelheim Vetmedica GmbH |
新規のブタインフルエンザワクチン
|
AU2017329672B2
(en)
|
2016-09-20 |
2023-07-27 |
Boehringer Ingelheim Vetmedica Gmbh |
New promoters
|
WO2018064523A1
(en)
|
2016-09-30 |
2018-04-05 |
Genvec, Inc. |
Adenovectors for delivery of therapeutic genetic material into t cells
|
WO2018067582A2
(en)
|
2016-10-03 |
2018-04-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hiv-1 env fusion peptide immunogens and their use
|
WO2018071817A1
(en)
|
2016-10-14 |
2018-04-19 |
Dimension Therapeutics |
Use of tonicifying agents to enhance recombinant adeno-associated virus yield
|
TW202300515A
(zh)
|
2016-10-20 |
2023-01-01 |
法商賽諾菲公司 |
抗chikv抗體及其用途
|
US11186635B2
(en)
|
2016-10-25 |
2021-11-30 |
Institut National De La Santé Et De La Recherché Médical (Inserm) |
Monoclonal antibodies binding to the CD160 transmembrane isoform
|
EP3532095A1
(en)
|
2016-10-25 |
2019-09-04 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Prefusion coronavirus spike proteins and their use
|
FR3058143B1
(fr)
|
2016-10-27 |
2021-03-12 |
Univ Grenoble Alpes |
Nanocorps anti-tau
|
CN110139933B
(zh)
|
2016-11-09 |
2024-03-08 |
英特瑞克斯顿股份有限公司 |
共济蛋白表达构建体
|
WO2018109220A2
(en)
|
2016-12-16 |
2018-06-21 |
Institute For Research In Biomedicine |
Novel recombinant prefusion rsv f proteins and uses thereof
|
US20190343927A1
(en)
|
2017-01-30 |
2019-11-14 |
Brainvectis |
Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias
|
CN118021947A
(zh)
|
2017-01-31 |
2024-05-14 |
辉瑞大药厂 |
脑膜炎奈瑟菌组合物及其使用方法
|
CN110392697A
(zh)
|
2017-03-02 |
2019-10-29 |
国家医疗保健研究所 |
对nectin-4具有特异性的抗体及其用途
|
US11578136B2
(en)
|
2017-03-16 |
2023-02-14 |
Innate Pharma |
Compositions and methods for treating cancer
|
JP7142643B2
(ja)
|
2017-03-22 |
2022-09-27 |
ウルトラジェニックス ファーマシューティカル インコーポレイテッド |
Hdac阻害剤またはrepタンパク質を伴う細胞培養方法
|
US11235056B2
(en)
|
2017-03-24 |
2022-02-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Glycan-masked engineered outer domains of HIV-1 gp120 and their use
|
WO2018178051A1
(en)
|
2017-03-28 |
2018-10-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Scgb1a1 polymorphism for the prediction and therapy or prevention of primary graft dysfunction
|
EP3388072A1
(en)
|
2017-04-10 |
2018-10-17 |
Universität Leipzig |
Ubiquinone-independent cytoplasmic dihydroorotate dehydrogenase for use as medicament
|
CA3066047A1
(en)
|
2017-06-14 |
2018-12-20 |
Technische Universitat Dresden |
Methods and means for genetic alteration of genomes utilizing designer dna recombining enzymes
|
US11174322B2
(en)
|
2017-07-24 |
2021-11-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies and peptides to treat HCMV related diseases
|
WO2019038420A1
(en)
|
2017-08-25 |
2019-02-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOCLAST DISEASES
|
MX2020003219A
(es)
|
2017-09-21 |
2020-07-20 |
Imcheck Therapeutics Sas |
Anticuerpos que tienen especificidad para btn2 y usos de los mismos.
|
WO2019079240A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
US20200237799A1
(en)
|
2017-10-16 |
2020-07-30 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
WO2019079337A1
(en)
|
2017-10-16 |
2019-04-25 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE
|
CA3092935A1
(en)
|
2018-03-06 |
2019-09-12 |
Precigen, Inc. |
Hepatitis b vaccines and uses of the same
|
KR20210023983A
(ko)
|
2018-06-18 |
2021-03-04 |
이나뜨 파르마 |
암을 치료하기 위한 조성물 및 방법
|
US20210361318A1
(en)
|
2018-07-02 |
2021-11-25 |
Voyager Therapeutics, Inc. |
Cannula system and use thereof
|
WO2020010042A1
(en)
|
2018-07-02 |
2020-01-09 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
AU2019368218A1
(en)
|
2018-10-22 |
2021-05-27 |
New York University |
Recombinant GP120 protein with V1-loop deletion
|
CN112955169A
(zh)
|
2018-10-29 |
2021-06-11 |
法国国家卫生及研究医学协会 |
用于肌萎缩性侧索硬化疗法中的胆固醇24-水解酶的表达载体
|
WO2020148207A1
(en)
|
2019-01-14 |
2020-07-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Human monoclonal antibodies binding to hla-a2
|
JP2022517029A
(ja)
|
2019-01-15 |
2022-03-03 |
アンセルム(アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル) |
変異したインターロイキン-34(il-34)ポリペプチドおよび治療におけるその使用
|
CA3134122A1
(en)
|
2019-03-20 |
2020-09-24 |
Imcheck Therapeutics Sas |
Antibodies having specificity for btn2 and uses thereof
|
WO2020193441A1
(en)
|
2019-03-22 |
2020-10-01 |
Université de Paris |
New inhibitors of lrrk2/pp1 interaction
|
WO2020193520A1
(en)
|
2019-03-25 |
2020-10-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of taupathy disorders by targeting new tau species
|
EP3972997A1
(en)
|
2019-05-20 |
2022-03-30 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Novel anti-cd25 antibodies
|
EP3972631A2
(en)
|
2019-05-21 |
2022-03-30 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Expression vector for cholesterol 24-hydrolase in therapy of rett syndrome
|
US20220259295A1
(en)
|
2019-06-20 |
2022-08-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method useful in tolerance induction therapy and kits therefore
|
US20220251567A1
(en)
|
2019-07-10 |
2022-08-11 |
Inserm (Institut National De La Santè Et De La Recherche Médicale) |
Methods for the treatment of epilepsy
|
JP2022541200A
(ja)
|
2019-07-16 |
2022-09-22 |
インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル) |
Cd38に特異性を有する抗体及びその使用
|
WO2021009299A1
(en)
|
2019-07-17 |
2021-01-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Bcl-xl:fkbp12 fusion proteins suitable for screening agents capable of slowing down the aging process
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
JP2022543259A
(ja)
|
2019-08-02 |
2022-10-11 |
オレガ・バイオテック |
新規il-17b抗体
|
US11414785B2
(en)
|
2019-08-13 |
2022-08-16 |
Waters Technologies Corporation |
Affinity resins and sample preparation devices based on cartilaginous fish IgNAR derived binding domains
|
EP4025206A1
(en)
|
2019-09-02 |
2022-07-13 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods and compositions for treating pax6- deficiency related disease
|
CN114341183B
(zh)
|
2019-09-04 |
2024-04-16 |
Inserm(法国国家健康医学研究院) |
Il20-rb特异性抗体及其用于治疗慢性阻塞性肺疾病急性恶化的用途
|
WO2021048171A1
(en)
|
2019-09-10 |
2021-03-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method to improve phagocytosis
|
EP4034153A1
(en)
|
2019-09-24 |
2022-08-03 |
Université catholique de Louvain |
Modified vesicular stomatitis virus glycoprotein and uses thereof for the treatment of brain tumors
|
CN114450304B
(zh)
|
2019-09-27 |
2023-12-12 |
国家医疗保健研究所 |
抗苗勒管抑制物质抗体及其用途
|
WO2021058729A1
(en)
|
2019-09-27 |
2021-04-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-müllerian inhibiting substance type i receptor antibodies and uses thereof
|
WO2021072129A2
(en)
|
2019-10-08 |
2021-04-15 |
Trustees Of Boston College |
Proteins containing multiple, different unnatural amino acids and methods of making and using such proteins
|
EP3812008A1
(en)
|
2019-10-23 |
2021-04-28 |
Gamamabs Pharma |
Amh-competitive antagonist antibody
|
CN110656090B
(zh)
*
|
2019-10-28 |
2023-06-30 |
嘉兴安宇生物科技有限公司 |
一种表达质粒、用于包装容量增加的二代腺病毒的细胞株及其应用
|
CN110714027A
(zh)
*
|
2019-10-28 |
2020-01-21 |
嘉铭(固安)生物科技有限公司 |
一种表达质粒、用于包装二代腺病毒的细胞株及其应用
|
WO2021099394A1
(en)
|
2019-11-19 |
2021-05-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antisense oligonucleotides and their use for the treatment of cancer
|
JP2023502712A
(ja)
|
2019-11-21 |
2023-01-25 |
インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル) |
抗pd-1/il-15免疫サイトカインによる新しいpd-1標的免疫療法
|
WO2021116119A1
(en)
|
2019-12-09 |
2021-06-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to her4 and uses thereof
|
EP4090365A1
(en)
|
2020-01-15 |
2022-11-23 |
Immatics Biotechnologies GmbH |
Antigen binding proteins specifically binding prame
|
IL295129A
(en)
|
2020-01-30 |
2022-09-01 |
Umoja Biopharma Inc |
Bispecific transduction enhancer
|
BR112022015628A2
(pt)
|
2020-02-11 |
2022-09-27 |
Us Health |
Vacina de sars-cov-2
|
WO2021175954A1
(en)
|
2020-03-04 |
2021-09-10 |
Imcheck Therapeutics Sas |
Antibodies having specificity for btnl8 and uses thereof
|
US11213482B1
(en)
|
2020-03-05 |
2022-01-04 |
University of Pittsburgh—Of the Commonwealth System of Higher Educat |
SARS-CoV-2 subunit vaccine and microneedle array delivery system
|
CN115484978A
(zh)
|
2020-03-05 |
2022-12-16 |
尼奥克斯医疗有限公司 |
使用免疫细胞治疗癌症的方法和组合物
|
US11773391B2
(en)
|
2020-04-01 |
2023-10-03 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Therapeutic and diagnostic target for SARS-CoV-2 and COVID-19
|
CN116096407A
(zh)
|
2020-04-29 |
2023-05-09 |
美国政府(由卫生和人类服务部的部长所代表) |
重组人偏肺病毒f蛋白及其用途
|
EP4149558A1
(en)
|
2020-05-12 |
2023-03-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to treat cutaneous t-cell lymphomas and tfh derived lymphomas
|
WO2021247995A2
(en)
|
2020-06-04 |
2021-12-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating neuropathic pain
|
EP4153636A1
(en)
|
2020-06-29 |
2023-03-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-protein s single-domain antibodies and polypeptides comprising thereof
|
MX2023001615A
(es)
|
2020-08-07 |
2023-03-08 |
Spacecraft Seven Llc |
Genoterapia con placofilina-2 (pkp2) mediante el uso de vector de aav.
|
WO2022035860A2
(en)
|
2020-08-10 |
2022-02-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Replication-competent adenovirus type 4-hiv env vaccines and their use
|
JP2023540732A
(ja)
|
2020-09-04 |
2023-09-26 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
抗ceacam5抗体及びコンジュゲート並びにそれらの使用
|
JP2023554587A
(ja)
|
2020-11-12 |
2023-12-28 |
アンセルム(アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル) |
Sars-cov-2 スパイクタンパク質の受容体結合ドメインにコンジュゲートまたは融合している抗体およびワクチン目的でのそれらの使用
|
WO2022136508A1
(en)
|
2020-12-23 |
2022-06-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Chlamydia vaccine based on targeting momp vs4 antigen to antigen presenting cells
|
WO2022152698A1
(en)
|
2021-01-12 |
2022-07-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of npdk-d to evaluate cancer prognosis
|
WO2022159575A1
(en)
|
2021-01-20 |
2022-07-28 |
Bioentre Llc |
Ctla4-binding proteins and methods of treating cancer
|
KR20230143150A
(ko)
|
2021-01-27 |
2023-10-11 |
우모자 바이오파마 인코포레이티드 |
항-cd19 키메라 항원 수용체를 발현하는 세포를 생성하기 위한 렌티바이러스
|
JP2024504195A
(ja)
|
2021-01-29 |
2024-01-30 |
アンセルム(アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル) |
クラミジア・トラコマチス抗原性ポリペプチドおよびワクチン目的のためのその使用
|
WO2022184805A1
(en)
|
2021-03-03 |
2022-09-09 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding sars-cov-2 antigenic peptides in complex with a major histocompatibility complex protein
|
WO2022200469A1
(en)
|
2021-03-24 |
2022-09-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
A dominant negative protein of rad51 for treating cancer
|
EP4322937A1
(en)
|
2021-04-14 |
2024-02-21 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
New method to improve the anti-tumoral activity of macrophages
|
WO2022219080A1
(en)
|
2021-04-14 |
2022-10-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to improve nk cells cytotoxicity
|
WO2022232648A1
(en)
|
2021-04-29 |
2022-11-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Prefusion-stabilized lassa virus glycoprotein complex and its use
|
CA3215344A1
(en)
|
2021-04-30 |
2022-11-03 |
Kalivir Immunotherapeutics, Inc. |
Oncolytic viruses for modified mhc expression
|
AU2022270361A1
(en)
|
2021-05-05 |
2023-11-16 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding prame
|
JP2024517377A
(ja)
|
2021-05-13 |
2024-04-22 |
ウニベルシダージ ド アルガルヴェ |
神経変性疾患に用いるための単離または人工ヌクレオチド
|
AU2022318257A1
(en)
|
2021-07-27 |
2024-02-08 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding ct45
|
WO2023012165A1
(en)
|
2021-08-02 |
2023-02-09 |
Universite De Montpellier |
Compositions and methods for treating cmt1a or cmt1e diseases with rnai molecules targeting pmp22
|
AU2022323509A1
(en)
|
2021-08-03 |
2024-02-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hiv-1 vaccination and samt-247 microbicide to prevent hiv-1 infection
|
EP4130038A1
(en)
|
2021-08-03 |
2023-02-08 |
Institut national de recherche pour l'agriculture, l'alimentation et l'environnement |
Anti-il-2 antibody, complex comprising it, and uses thereof
|
EP4340855A1
(en)
|
2021-08-13 |
2024-03-27 |
Triovance Holding LLC |
A skin substitute composition and methods of producing and using the same
|
US20230241118A1
(en)
|
2021-10-20 |
2023-08-03 |
University Of Rochester |
Rejuvenation treatment of age-related white matter loss
|
US20230270818A1
(en)
|
2021-11-02 |
2023-08-31 |
University Of Rochester |
Tcf7l2 mediated remyelination in the brain
|
AU2022386716A1
(en)
|
2021-11-15 |
2024-05-02 |
Technische Universität Dresden |
Site-specific recombinases for efficient and specific genome editing
|
CA3238660A1
(en)
|
2021-11-17 |
2023-05-25 |
Institut National De La Sante Et De La Recherche Medicale |
Universal sarbecovirus vaccines
|
WO2023091696A1
(en)
|
2021-11-19 |
2023-05-25 |
Christiana Care Gene Editing Institute, Inc. |
Adenovirus delivery system for cancer treatment
|
WO2023099578A1
(en)
|
2021-12-01 |
2023-06-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neutralizing anti-cd95l monoclonal antibodies
|
EP4209508A1
(en)
|
2022-01-11 |
2023-07-12 |
Centre national de la recherche scientifique |
Nanobodies for the deneddylating enzyme nedp1
|
WO2023150563A1
(en)
|
2022-02-01 |
2023-08-10 |
Cornell University |
Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy associated with friedreich ataxia
|
WO2023156437A1
(en)
|
2022-02-16 |
2023-08-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-robo4 human monoclonal antibodies and uses thereof for the treatment of cancer
|
WO2023161412A1
(en)
|
2022-02-25 |
2023-08-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for preventing the cleavage of cd95l by metalloproteases
|
WO2023170239A1
(en)
|
2022-03-09 |
2023-09-14 |
Merck Patent Gmbh |
Methods and tools for conjugation to antibodies
|
WO2023170296A1
(en)
|
2022-03-11 |
2023-09-14 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Nucleic acid system to specifically reprogram b and t cells and uses thereof
|
WO2023192835A1
(en)
|
2022-03-27 |
2023-10-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Base-covered hiv-1 envelope ectodomains and their use
|
WO2023196898A1
(en)
|
2022-04-07 |
2023-10-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Beta globin mimetic peptides and their use
|
WO2023217904A1
(en)
|
2022-05-10 |
2023-11-16 |
Institut National de la Santé et de la Recherche Médicale |
Syncitin-1 fusion proteins and uses thereof for cargo delivery into target cells
|
WO2023240287A1
(en)
|
2022-06-10 |
2023-12-14 |
Bioentre Llc |
Combinations of ctla4 binding proteins and methods of treating cancer
|
WO2024011237A1
(en)
|
2022-07-08 |
2024-01-11 |
Cornell University |
Methods and pharmaceutical compositions for the treatment and the prevention of alzheimers disease
|
WO2024017990A1
(en)
|
2022-07-21 |
2024-01-25 |
Institut National de la Santé et de la Recherche Médicale |
Methods and compositions for treating chronic pain disorders
|
WO2024052503A1
(en)
|
2022-09-08 |
2024-03-14 |
Institut National de la Santé et de la Recherche Médicale |
Antibodies having specificity to ltbp2 and uses thereof
|
WO2024056668A1
(en)
|
2022-09-12 |
2024-03-21 |
Institut National de la Santé et de la Recherche Médicale |
New anti-itgb8 antibodies and its uses thereof
|
WO2024061930A1
(en)
|
2022-09-22 |
2024-03-28 |
Institut National de la Santé et de la Recherche Médicale |
New method to treat and diagnose peripheral t-cell lymphoma (ptcl)
|
WO2024074571A1
(en)
|
2022-10-05 |
2024-04-11 |
Institut National de la Santé et de la Recherche Médicale |
Dc-targeting vaccine against nipah virus infection
|
WO2024079317A1
(en)
|
2022-10-14 |
2024-04-18 |
Institut National de la Santé et de la Recherche Médicale |
Methods and pharmaceutical composition for the treatment of alpha-synucleinopathies
|
PT118269A
(pt)
|
2022-10-20 |
2024-04-22 |
Univ Aveiro |
Pkmyt1 for use in regenerative medicine
|
WO2024091824A1
(en)
|
2022-10-26 |
2024-05-02 |
Ada Forsyth Institute, Inc. |
Differentiation and reprogramming of chondrocyte
|
WO2024097992A2
(en)
|
2022-11-04 |
2024-05-10 |
Umoja Biopharma, Inc. |
Particles displaying adhesion-molecule fusions
|
WO2024098028A2
(en)
|
2022-11-04 |
2024-05-10 |
Umoja Biopharma, Inc. |
Lentiviral particles displaying fusion molecules and uses thereof
|